The effects of cocaine and amphetamine use during pregnancy on the newborn: Myth versus reality

Journal of Addictive Diseases

Volumn 30, Issue 1, 2011, Pages 1-5

  Terplan, Mishka ^a   Wright, Tricia ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; COCAINE;

BRAIN INJURY; CIGARETTE SMOKING; DRUG EFFECT; DRUG USE; FETUS DEVELOPMENT; HEARING IMPAIRMENT; HEART DISEASE; HUMAN; INTRAUTERINE GROWTH RETARDATION; META ANALYSIS (TOPIC); MOTHER; MOTOR DYSFUNCTION; PLACENTA FUNCTION; PREGNANCY; PREGNANT WOMAN; PRENATAL EXPOSURE; REVIEW; SEIZURE; SOLUTIO PLACENTAE; SPEECH DISORDER; SUDDEN INFANT DEATH SYNDROME; TERATOGENICITY; UROGENITAL TRACT MALFORMATION;

ABNORMALITIES, DRUG-INDUCED; AMPHETAMINE; COCAINE; FEMALE; HUMANS; INFANT, NEWBORN; MATERNAL BEHAVIOR; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 78651352540     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2011.532048     Document Type: Review

References (46)

1. Keegan J, Parva M, Finnegan M, Gerson A, Belden M. Addiction in pregnancy. J Addict Dis 2010; 29:175-91.
2. Chasnoff IJ, Burns WJ, Schnoll SH, Burns KA. Cocaine use in pregnancy. N Engl J Med 1985; 313:666-9.
3. Ryan L, Ehrlich S, Finnegan L. Cocaine abuse in pregnancy: effects on the fetus and newborn. Neurotoxicol Teratol 1987; 9:295-9.
4. Bauchner H, Zuckerman B, McClain M, Frank D, Fried LE, Kayne H. Risk of sudden infant death syndrome among infants with in utero exposure to cocaine. J Pediatr 1988; 113:831-4.
5. Chasnoff IJ, Burns KA, Burns WJ. Cocaine use in pregnancy: perinatal morbidity and mortality. Neurotoxicol Teratol 1987; 9:291-3.
6. Doberczak TM, Shanzer S, Senie RT, Kandall SR. Neonatal neurologic and electroencephalographic effects of intrauterine cocaine exposure. J Pediatr 1988; 113:354-8.
7. Dixon SD, Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr 1989; 115:770-8.
8. Bingol N, Fuchs M, Diaz V, Stone RK, Gromisch DS. Teratogenicity of cocaine in humans. J Pediatr 1987; 110:93-96.
9. Chasnoff IJ, Chisum GM, KaplanWE. Maternal cocaine use and genitourinary tract malformations. Teratology 1988; 37:201-4.
10. Chavez GF, Mulinare J, Cordero JF. Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. JAMA 1989; 262: 795-8.
11. Little BB, Snell LM, Klein VR, Gilstrap LC,3rd. Cocaine abuse during pregnancy: maternal and fetal implications. Obstet Gynecol 1989; 73:157-60.
12. Kramer LD, Locke GE, Ogunyemi A, Nelson L. Neonatal cocaine-related seizures. J Child Neurol 1990; 5:60-4.
13. Shih L, Cone-Wesson B, Reddix B. Effects of maternal cocaine abuse on the neonatal auditory system. Int J Pediatr Otorhinolaryngol 1988; 15:245-51.
14. van Baar A. Development of infants of drug dependent mothers. J Child Psychol Psychiatry 1990; 31:911-20.
15. Fetters L, Tronick EZ. Neuromotor development of cocaine-exposed and control infants from birth through 15 months: poor and poorer performance. Pediatrics 1996; 98:938-43.
16. Lewis KD, Bennett B, Schmeder NH. The care of infants menaced by cocaine abuse. MCN Am J Matern Child Nurs 1989; 14:324-9.
17. Reinarman CLH, ed. Crack in America: demon drugs and social justice. Los Angeles, CA: Unversity of California Press, 1997
18. Gomez L.Misconceiving mothers: legislators, prosecutors, and the politics of prenatal drug exposure. Philadelphia: Temple University Press, 1997.
19. Fares I, McCulloch KM, Raju TN. Intrauterine cocaine exposure and the risk for sudden infant death syndrome: a meta-analysis. J Perinatol 1997; 17:179-82.
20. Addis A, Moretti ME, Ahmed Syed F, Einarson TR, KorenG. Fetal effects of cocaine: an updatedmeta-analysis. Reprod Toxicol 2001; 15:341-69.
21. Frank DA, AugustynM, Knight WG, Pell T, Zuckerman B. Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review. JAMA 2001; 285:1613-25.
22. Rose-Jacobs R, Cabral H, Posner MA, Epstein J, FrankDA. Do "we just know"? Masked assessors ability to accurately identify childrenwith prenatal cocaine exposure. J Dev Behav Pediatr 2002; 23:340-6.
23. Lester BM, LaGasse LL, Seifer R. Cocaine exposure and children: the meaning of subtle effects. Science 1998; 282:633-4.
24. Lester BM. The Maternal Lifestyles Study. Ann N Y Acad Sci 1998; 846:296-305.
25. Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S. History of the methamphetamine problem. J Psychoactive Drugs 2000; 32:137-141.
26. NIDA. Research Report Series: methamphetamine abuse and addiction. Available at: http://www.drugabuse. gov/ResearchReports/Methamph/Methamph.html. Accessed September 20, 2010.
27. NIDA. Epidemiologic trends in drug abuse advance report, June 2002.Available at: www.drugabuse.gov/about/ organization/cewg/AdvancedRep/ 602ADV/602adv.html. Accessed November, 24, 2010
28. Terplan M, Smith EJ, Kozloski MJ, Pollack HA. Methamphetamine use among pregnantwomen. Obstet Gynecol 2009; 113:1285-91.
29. Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Grotta SD, Liu J, Lester BM. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 2006; 118:1149-56.
30. Lester BM, Lagasse LL. Children of addicted women. J Addict Dis 2010; 29:259-76.
31. Kandall S. Substance and shadow: women and addiction in the United States. Cambridge,MA: Harvard University Press, 1996.
32. Graham K, Koren G, Klein J, Schneiderman J, Greenwald M. Determination of gestational cocaine exposure by hair analysis. JAMA 1989; 262:3328-30.
33. Nora JJ, Trasler DG, Fraser FC. Malformations in mice induced by dexamphetamine sulphate. Lancet 1965; 2:1021-2.
34. Nora JJ, Vargo TA, Nora AH, Love KE, Mc- Namara DG. Dexamphetamine: a possible environmental trigger in cardiovascular malformations. Lancet 1970; 1:1290-1.
35. Levin JN. Amphetamine ingestion with biliary atresia. J Pediatr 1971; 79:130-1.
36. Dixon SD, Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr 1989; 115:770-8.
37. Baysal K, Brierley GP, Novgorodov S, Jung DW. Regulation of the mitochondrial Na+/Ca2+ antiport by matrix pH. Arch Biochem Biophys 1991; 291:383-9.
38. Bays J. Fetal vascular disruption with prenatal exposure to cocaine or methamphetamine. Pediatrics 1991; 87:416-8.
39. Hansen RL, Struthers JM, Gospe SM Jr. Visual evoked potentials and visual processing in stimulant drugexposed infants. Dev Med Child Neurol 1993; 35:798-805.
40. Thomas DB. Cleft palate, mortality and morbidity in infants of substance abusing mothers. J Paediatr Child Health 1995; 31:457-60.
41. Stewart JL, Meeker JE. Fetal and infant deaths associated with maternal methamphetamine abuse. J Anal Toxicol 1997; 21:515-7.
42. Forrester MB, Merz RD. Comparison of trends in gastroschisis and prenatal illicit drug use rates. J Toxicol Environ Health A 2006; 69:1253-9.
43. Saxen I. Associations between oral clefts and drugs taken during pregnancy. Int J Epidemiol 1975; 4: 37-44.
44. Vericker T, Macomber J, Golden O. Infants of depressed mothers living in poverty: opportunities to identify and serve. Brief 1, August 2010, TheUrban Institute.Available at: http://www.urban.org/url.cfm?ID=901377. Accessed November 23, 2010.
45. Murphy S, Rossennbaum M. Pregnant women on drugs: combating stereotypes and stigma. New Brunswick, NY: Rutgers University Press, 1999.
46. Klee H, JacksonM, Lewis S. Drug Misuse and motherhood. New York: Routledge, 2002.